$CTIC CTI BIOPHARMA CORP Insider Trading Week 31/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CTI BIOPHARMA CORP in week 31/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.53 | 300 | 759 | 572,904 | 573.2 K to 572.9 K (-0.05 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.52 | 300 | 756 | 573,204 | 573.5 K to 573.2 K (-0.05 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.52 | 100 | 252 | 573,504 | 573.6 K to 573.5 K (-0.02 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.51 | 1,500 | 3,765 | 573,604 | 575.1 K to 573.6 K (-0.26 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.51 | 100 | 251 | 575,104 | 575.2 K to 575.1 K (-0.02 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.50 | 800 | 2,000 | 575,204 | 576 K to 575.2 K (-0.14 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.50 | 1,000 | 2,495 | 576,004 | 577 K to 576 K (-0.17 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.49 | 600 | 1,494 | 577,004 | 577.6 K to 577 K (-0.10 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.49 | 400 | 994 | 577,604 | 578 K to 577.6 K (-0.07 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.48 | 200 | 496 | 578,004 | 578.2 K to 578 K (-0.03 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.47 | 800 | 1,976 | 578,204 | 579 K to 578.2 K (-0.14 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.47 | 600 | 1,479 | 579,004 | 579.6 K to 579 K (-0.10 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.46 | 2,000 | 4,920 | 579,604 | 581.6 K to 579.6 K (-0.34 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.46 | 1,100 | 2,701 | 581,604 | 582.7 K to 581.6 K (-0.19 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.45 | 1,300 | 3,185 | 582,704 | 584 K to 582.7 K (-0.22 %) |
Aug 06 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 2.45 | 900 | 2,201 | 584,004 | 584.9 K to 584 K (-0.15 %) |